Buprenorphine Tablet
Product Images NDC 58118-0460

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Buprenorphine (NDC 58118-0460). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Clinical Solutions Wholesale, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Buprenorphine-figure (Buprenorphine Figure)

An illustration showing the correct placement of a tablet under the tongue. The image depicts an open mouth with a hand positioning a sublingual tablet on the tongue's underside, demonstrating intended use for sublingual administration.*

FDA Label Image

Buprenorphine 8mg Sl Tablet 30ct Blister Card (Buprenorphine Label 8mg)

Label for Buprenorphine SL 8mg sublingual tablets. The label shows a quantity of 30 tablets and lists Clinical Solutions Wholesale as the distributor. The product is repackaged and distributed by Clinical Solutions Wholesale, LLC, with manufacturing by Sun Pharmaceutical Industries, NJ, USA. The label displays the NDC 58118-0460-8 and includes batch and expiration date information.*

FDA Label Image

Buprenorphine-str (Buprenorphine Str)

Chemical structure of Buprenorphine hydrochloride, showing its molecular arrangement with labeled functional groups and ring structures.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.